WGRX - NASDAQ
Wellgistics Health, Inc.
$0.72
-7.8%Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
At a Glance
Live SnapshotWellgistics Health, Inc. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.
Debt-to-Equity Ratio
High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.
Working Capital
Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.
Asset Composition
Capital-intensive business with significant long-term investments in property, equipment, or intangibles.
Financial Health Insight
Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.
Wellgistics Health, Inc. Balance Sheet
WGRX • NASDAQ
| Wellgistics Health, Inc. Balance Sheet | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|
ASSETS | |||
CURRENT ASSETS | |||
1M | 1.4K | 0.0 | |
1M | 1.4K | 0.0 | |
3.7M | 337K | 0.0 | |
2.7M | 337K | 0.0 | |
1M | 0.0 | 0.0 | |
9.5M | 0.0 | 0.0 | |
524.0 | 0.0 | 0.0 | |
875.4K | 0.0 | 0.0 | |
15.2M | 338.4K | 0.0 | |
NON-CURRENT ASSETS | |||
1.9M | 0.0 | 0.0 | |
16.2M | 0.0 | 0.0 | |
22.4M | 0.0 | 0.0 | |
38.6M | 0.0 | 0.0 | |
17.7K | 0.0 | 0.0 | |
1.6M | 0.0 | 0.0 | |
42.2M | 0.0 | 0.0 | |
57.3M | 338.4K | 0.0 | |
LIABILITIES | |||
CURRENT LIABILITIES | |||
21.3M | 1.1M | 5.3K | |
6.3M | 1M | 5.3K | |
14.9M | 67.8K | 0.0 | |
852K | 482.3K | 0.0 | |
12M | 350K | 0.0 | |
519.5K | 0.0 | 0.0 | |
245.8K | 0.0 | 0.0 | |
3.1M | 950K | 0.0 | |
38M | 2.9M | 5.3K | |
NON-CURRENT LIABILITIES | |||
11.5M | 350K | 0.0 | |
12.6M | 350K | 0.0 | |
1.6M | 0.0 | 0.0 | |
50.6M | 3.2M | 5.3K | |
SHAREHOLDERS' EQUITY | |||
5.1K | 4.5K | 0.0 | |
16.5M | -4K | 0.0 | |
-9.8M | -2.9M | -5.3K | |
6.7M | -2.9M | -5.3K | |
6.7M | -2.9M | -5.3K | |
SUMMARY | |||
57.3M | 338.4K | 0.0 | |
17.7K | 0.0 | 0.0 | |
25.1M | 700K | 0.0 | |
24.1M | 698.6K | 0.0 | |
69,990,333 | 69,990,333 | 69,990,333 |
SEC Filings
WGRX - Filing history and reports
No SEC filings available for WGRX
Related Guides
Continue your WGRX research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.